Elypta reports failed kidney cancer recurrence test validation
The urine-based diagnostic assay did not meet prespecified clinical criteria for monitoring tumor return after surgery. This outcome halts plans to file a regulatory submission.
Latest Elypta News & Updates
See the latest news and media coverage for Elypta. We track all announcements, press releases, and industry mentions in real time, all in one place.
Cancer risk testing and glycosaminoglycan biomarker company
elypta.com- Headquarters
- Solna, Sweden
- Founded year
- 2017
- Company type
- Private company
- Number of employees
- 29–50
- Industry
- Biotechnology & Medical Research
Last updated
Latest news about Elypta
In short: Elypta launched a urine analysis kit but halted regulatory plans after a failed cancer test validation.
Company announcements
Elypta is nominated for Medtech of the Year
The nomination recognizes Elypta's work in enabling earlier cancer detection, with Karl Bergman set to attend LSX in London in November.
Elypta welcomes three new team members
Andrea Boman joins as QA Manager, Flavia Plastino as Research Engineer, and Maria Aspenberg as QC Engineer, all with strong biomedical backgrounds.
Elypta is hiring a quality control engineer
The role focuses on enabling earlier detection of cancer. Interested candidates can find application details through the provided link.
Media coverage
Elypta Raises ?6 Million in a Late Seed Round Led by Industrifonden
STOCKHOLM, Jan. 23, 2020 /PRNewswire/ -- Elypta, the Swedish molecular diagnostics firm pioneering metabolism-based liquid biopsies, has raised ?6.1 million in a late seed funding...
Elyptas cancertest ska prövas i EU-projekt kring Lynchs syndrom
Det svenska diagnostikbolaget Elypta ska delta i ett stort europeiskt projekt för att möjliggöra tidig upptäckt av cancer hos personer med Lynch syndrom.
LSX Roundup: Startups Elypta, QuantiLight And Plexaa Debut New Tech
Back-to-back meetings at LSX? No time to attend the innovator showcase? Here is what you might have missed from medtech innovators at the LSX World...
With Positive Multi-Site Trial Data, Elypta Poised for Launch of Kidney Cancer Surveillance Test | 360Dx
The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file...
Never miss news about Elypta
Track Elypta and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Elypta competitors & trending companies
Browse news for competitors to Elypta and other trending companies.
A3P
Simsen Diagnostics
Guardant Health
Natera
GRAIL
Exact Sciences
Freenome
Personalis
Volition
Biovica
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC
Kriminalvården
Archus
Nyréns
Peab
MVB
VGR fastigheter
AIX
ByggDialog
Tengbom
LINK
Dynacon